Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,611 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00344773 | First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation | completed | Phase 2 | 46 | AstraZenecaINDUSTRY | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00388089 | Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | University of California, DavisOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer |
| completed |
| Phase 2 |
| 80 |
| SCRI Development Innovations, LLCOTHER |
| 1 |
| Jun 28, 2010 |
| clinicaltrials |
| NCT00193323 | Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients | completed | Phase 2 | 346 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00193349 | Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 60 | SCRI Development Innovations, LLCOTHER | 0 | Jun 28, 2010 | clinicaltrials |
| NCT00294931 | Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 50 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00308529 | Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | SCRI Development Innovations, LLCOTHER | 1 | Jun 22, 2010 | clinicaltrials |
| NCT01145924 | Transbronchial Needle Forceps for Endobronchial Ultrasound | unknown | Phase 2 | 50 | Heidelberg UniversityOTHER | 1 | Jun 17, 2010 | clinicaltrials |
| NCT00783471 | Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)(DOPERLO) | terminated | Phase 2 | 51 | Hellenic Cooperative Oncology GroupOTHER | 1 | Jun 16, 2010 | clinicaltrials |
| NCT00003154 | Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 19 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00006017 | Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer | completed | Phase 2 | 42 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00053300 | Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT01140958 | A Retrospective Pharmacoeconomic Study of Lung Cancer | unknown | — | 91 | Taipei Medical University WanFang HospitalOTHER | 0 | Jun 10, 2010 | clinicaltrials |
| NCT01141686 | Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers | completed | — | 90 | Taipei Medical University WanFang HospitalOTHER | 0 | Jun 10, 2010 | clinicaltrials |
| NCT01131429 | A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations | unknown | Phase 2 | 60 | Chinese PLA General HospitalOTHER | 1 | May 27, 2010 | clinicaltrials |
| NCT01130766 | Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 3 | 176 | Samsung Medical CenterOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT01130779 | The Continuation of Erlotinib | unknown | Phase 2 | 23 | Samsung Medical CenterOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT01000740 | A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa | completed | Phase 4 | 59 | AstraZenecaINDUSTRY | 1 | May 21, 2010 | clinicaltrials |
| NCT00113516 | A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 84 | PfizerINDUSTRY | 3 | May 18, 2010 | clinicaltrials |
| NCT01091376 | Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)(RT0901) | unknown | Phase 2 | 75 | Zhejiang Cancer HospitalOTHER | 1 | May 17, 2010 | clinicaltrials |
| NCT01124253 | Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)(Dengshan) | completed | Phase 3 | 250 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 17, 2010 | clinicaltrials |
| NCT00956280 | Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer | completed | — | 100 | AstraZenecaINDUSTRY | 1 | May 13, 2010 | clinicaltrials |
| NCT00318136 | A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) | completed | Phase 2 | 47 | Genentech, Inc.INDUSTRY | 0 | May 11, 2010 | clinicaltrials |
| NCT00198393 | Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV | completed | Phase 2 | 126 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Apr 30, 2010 | clinicaltrials |
| NCT00185913 | Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers | completed | — | 50 | Stanford UniversityOTHER | 1 | Apr 22, 2010 | clinicaltrials |
| NCT01105182 | Radiofrequency Ablation Combined With Chemotherapy for Pulmonary Tumors(FACPT) | unknown | — | 48 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Apr 16, 2010 | clinicaltrials |
| NCT01104233 | Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) With LAP Protector | unknown | — | 80 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Apr 15, 2010 | clinicaltrials |
| NCT00063388 | Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer | completed | Phase 2 | 66 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2010 | clinicaltrials |
| NCT00034541 | Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 32 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00097214 | Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 57 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00097227 | Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 165 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00037713 | Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG | completed | Phase 3 | 515 | Eli Lilly and CompanyINDUSTRY | 0 | Apr 8, 2010 | clinicaltrials |
| NCT00387322 | Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | completed | Phase 1 / Phase 2 | 42 | University of California, DavisOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00054899 | An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer | completed | Phase 1 | 18 | EpimmuneINDUSTRY | 1 | Mar 24, 2010 | clinicaltrials |
| NCT01089894 | Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung Tumors | unknown | — | 90 | National Taiwan University HospitalOTHER | 1 | Mar 19, 2010 | clinicaltrials |
| NCT00569114 | Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients | completed | Phase 1 | 45 | Tragara Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 17, 2010 | clinicaltrials |
| NCT00884520 | An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037(VM4-037) | completed | Early Phase 1 | 16 | Siemens Molecular ImagingINDUSTRY | 1 | Mar 16, 2010 | clinicaltrials |
| NCT01034748 | A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers | completed | Phase 1 | 6 | PfizerINDUSTRY | 1 | Mar 12, 2010 | clinicaltrials |
| NCT00418743 | Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC) | unknown | — | 138 | Groupe Francais De Pneumo-CancerologieOTHER | 1 | Mar 9, 2010 | clinicaltrials |
| NCT00576914 | Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer | unknown | Phase 3 | 1,108 | Chinese Academy of SciencesOTHER_GOV | 1 | Mar 9, 2010 | clinicaltrials |
| NCT00456716 | Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma | completed | Phase 2 | 5 | Swedish Medical CenterOTHER | 1 | Mar 4, 2010 | clinicaltrials |
| NCT00099879 | Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer | terminated | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 7 | Mar 2, 2010 | clinicaltrials |
| NCT00103831 | Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 2 | Mar 2, 2010 | clinicaltrials |
| NCT00359450 | Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) | terminated | Phase 2 | 186 | Bristol-Myers SquibbINDUSTRY | 8 | Mar 2, 2010 | clinicaltrials |
| NCT00909558 | Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer | suspended | Phase 1 | 24 | Envita Medical Center, Inc.INDUSTRY | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00277329 | Study of XL999 in Patients With Non-small Cell Lung Cancer | terminated | Phase 2 | 9 | Symphony Evolution, Inc.INDUSTRY | 1 | Feb 22, 2010 | clinicaltrials |
| NCT00491699 | Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer | terminated | Phase 1 | 2 | Symphony Evolution, Inc.INDUSTRY | 1 | Feb 19, 2010 | clinicaltrials |
| NCT00915330 | Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy | completed | N/A | 164 | Maggiore Bellaria Hospital, BolognaOTHER | 1 | Feb 19, 2010 | clinicaltrials |
| NCT00143455 | Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer | completed | Phase 3 | 485 | PfizerINDUSTRY | 13 | Feb 18, 2010 | clinicaltrials |
| NCT00174772 | Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 72 | SanofiINDUSTRY | 8 | Feb 17, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Jun 29, 2010source: clinicaltrials